Pyrazinoic Acid

Pyrazinoic Acid

SCHEMBL27703290

CC(N)=O.O=C(O)c1cnccn1

nearest known ligand 0.80

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.80
▸ NAPRT Q6XQN6 2/20 0.80
▸ HCAR2 Q8TDS4 1/20 0.80
▸ ADORA3 P0DMS8 1/20 0.70
▸ TSHR P16473 1/20 0.70
▸ MC4R P32245 1/20 0.70
▸ ADRA1A P35348 1/20 0.70
▸ MC3R P41968 1/20 0.70
▸ BAZ2B Q9UIF8 1/20 0.53
▸ SMN1; SMN2 Q16637 5/20 0.45
▸ GAA P10253 2/20 0.44
▸ NPC1 O15118 4/20 0.44
▸ RAB9A P51151 4/20 0.44
▸ HDAC3 O15379 1/20 0.41
▸ HDAC1 Q13547 1/20 0.41
▸ HDAC2 Q92769 1/20 0.41
▸ HDAC8 Q9BY41 1/20 0.41
▸ HDAC6 Q9UBN7 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ LMNA P02545 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pyrazinoic Acid SCHEMBL27659395 0.90 KDM4E (0.91) KDM4ENAPRTHCAR2ADORA3TSHR
Pyrazinoic Acid SCHEMBL29651929 0.89 — —
Pyrazinoic Acid SCHEMBL23757 0.89 — —
Pyrazinoic Acid SCHEMBL27366253 0.88 KDM4E (0.80) KDM4ENAPRTHCAR2ADORA3TSHR
Pyrazinamide SCHEMBL28114417 0.88 ADORA3 (0.84) KDM4ENAPRTHCAR2ADORA3TSHR
Pyrazinoic Acid SCHEMBL6631652 0.87 KDM4E (0.95) KDM4ENAPRTHCAR2ADORA3TSHR
Pyrazinoic Acid SCHEMBL9478226 0.87 KDM4E (0.95) KDM4ENAPRTHCAR2ADORA3TSHR
Pyrazinoic Acid SCHEMBL10349317 0.87 KDM4E (0.95) KDM4ENAPRTHCAR2ADORA3TSHR
Pyrazinoic Acid SCHEMBL9478203 0.87 KDM4E (0.95) KDM4ENAPRTHCAR2ADORA3TSHR
Pyrazinoic Acid SCHEMBL8335237 0.87 KDM4E (0.95) KDM4ENAPRTHCAR2ADORA3TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101076331-A Compositions comprising nicotinic acid receptor partial agonists for the treatment of rubeosis and lipid-related disorders ARENA PHARM INC (US) 2007-11-21 — — CN disclosed
Send feedback